Advertisement OXIS introduces OTC joint pain relief supplement ErgoFlex - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

OXIS introduces OTC joint pain relief supplement ErgoFlex

OXIS International has introduced ErgoFlex, a new dietary supplement for the relief of joint pain.

OXIS claims that ErgoFlex is the only joint health complex containing the powerful antioxidant Ergothioneine (ERGO), and is specifically formulated to help the body fight the pain of joint inflammation and maintain optimal joint health.

ErgoFlex is available in 60-capsule containers at a retail price of $39.95.

OXIS is supporting the ErgoFlex marketing program with a pilot clinical study evaluating the benefits of the unique ErgoFlex formula for joint pain, inflammation and range of motion.

The study is nearing completion, and involves subjects with mild-to-moderate joint pain who were not previously receiving any medication or treatment for this ailment.

In the study, the patients are taking two capsules of ErgoFlex each day for six weeks, and will be followed for a further six weeks after they stop taking ErgoFlex.

OXIS president Bernie Landes said that they are delighted and proud to launch ErgoFlex, their first ERGO-based product and an important entrant in the multi-billion dollar US market for non-prescription joint health products.

"While most joint pain products only address the symptoms, ErgoFlex targets and relieves oxidative stress, which oftentimes is the underlying cause of joint ailments," Landes said.

It also provides a suite of extensively researched natural ingredients that help maintain the structural integrity of joints and relieve pain."